{"database": "lobbying", "table": "lobbying_activities", "rows": [[1813819, "0c037a8d-ae12-4b3d-a940-e15632243966", "Q1", "ARNALL GOLDEN GREGORY, LLP", 400713137, "PHARMA AND BIOPHARMA OUTSOURCING ASSOCIATION", 2016, "first_quarter", "MED", "FDA oversight issues of generic drugs; issues regarding generic drug user fees; 21st Century CURES Act; Innovation for Healthier Americans Act", "HOUSE OF REPRESENTATIVES,SENATE", null, null, 0, 0, "2016-04-19T10:40:36.057000-04:00"]], "columns": ["id", "filing_uuid", "filing_type", "registrant_name", "registrant_id", "client_name", "filing_year", "filing_period", "issue_code", "specific_issues", "government_entities", "income_amount", "expense_amount", "is_no_activity", "is_termination", "received_date"], "primary_keys": ["id"], "primary_key_values": ["1813819"], "units": {}, "query_ms": 0.6117509983596392, "source": "Federal Register API & Regulations.gov API", "source_url": "https://www.federalregister.gov/developers/api/v1", "license": "Public Domain (U.S. Government data)", "license_url": "https://www.regulations.gov/faq"}